News Sentiment

POM sentiment intelligence

POMDOCTOR LIMITED American Depositary Shares news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 48 Balanced news tone 40 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Pharmaceutical Retailers Read-through group
Latest close 1.53 Week of 10 Jul 2026
Weighted tone 48/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

83/100 classification confidence.

Company focus 40

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-4.4% over one week, -16.3% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

POMDOCTOR LIMITED Advances Healthcare Data Asset Strategy to Strengthen AI-Powered Chronic Disease Management Capabilities

Market Reaction

Price moving ahead of tone

61/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 83/100 classification
One-week reaction -4.4% Price reacting lower
Trend fit Trend inactive -16.3% over four weeks
Fair value -93.1% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 8
Neutral 22
Negative 10

Relevance

Why the article matched

Direct first
Direct company coverage 40
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 6
TradingKey 5
Market source 4
PR Newswire 3
Investing.com 3
MT Newswires 2
Simply Wall Street 2
Investing.com Canada 1

Event Lens

What the news is about

Classified themes
Market update 26
Analyst action 4
Earnings 4
Regulatory and legal 3
Macro sensitivity 1
Deals and strategy 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 40
Stock Titan Direct company coverage

POMDOCTOR LIMITED (POM) expands AI-powered chronic disease data platform

POMDOCTOR LIMITED is strengthening its AI-powered chronic disease management platform by building a comprehensive healthcare data ecosystem. The company leverages real-world data from wearables, remote monitoring, and patient interactions to improve AI models and provide personal

Tone
Positive 74/100
Event
Market update
Published
15 Jul 2026 12:13
Source
Stock Titan
Stock Titan Direct company coverage

Pomdoctor Connects Wearables, Doctors and Health Data for AI Care

Pomdoctor (NASDAQ: POM) is advancing its healthcare data strategy to enhance AI-powered chronic disease management by integrating real-world data from various sources including wearables, remote patient monitoring systems, and physician interactions. The company aims to build a c

Tone
Positive 74/100
Event
Market update
Published
15 Jul 2026 12:13
Source
Stock Titan
Market source Direct company coverage

POMDOCTOR LIMITED Regains Compliance with Nasdaq Bid Price Requirement

POMDOCTOR LIMITED (NASDAQ: POM) announced its regaining compliance with Nasdaq's minimum bid price requirement of $1.00 per share. This follows a previous notification on January 29, 2026, when the company's American Depositary Shares fell below the threshold. The stock has since

Tone
Positive 85/100
Event
Market update
Published
13 Jul 2026 12:09
Source
Market source
Investing.com Canada Direct company coverage

Pomdoctor regains compliance with Nasdaq minimum bid price rule By Investing.com

Pomdoctor Limited has regained compliance with Nasdaq's minimum bid price requirement after its American Depositary Shares maintained a closing bid price of $1.00 or higher for 10 consecutive business days. The company had previously received a deficiency notice in January 2026.

Tone
Positive 62/100
Event
Market update
Published
13 Jul 2026 12:09
Source
Investing.com Canada
Stock Titan Direct company coverage

Pomdoctor pushes AI-powered chronic disease monitoring with wearables

POMDOCTOR (NASDAQ: POM) has announced its continued advancement in AI-enabled chronic disease management, integrating AI analytics, remote patient monitoring, and wearables to create a predictive, continuous, and personalized healthcare ecosystem. The company highlights the signi

Tone
Positive 65/100
Event
Market update
Published
09 Jul 2026 11:39
Source
Stock Titan
The Manila Times Direct company coverage

POMDOCTOR LIMITED Announces Strategic Upgrade Toward Infrastructure for Predictive Healthcare Data and Services

POMDOCTOR LIMITED (NASDAQ: POM) has announced a strategic upgrade, repositioning itself as a foundational infrastructure provider for predictive healthcare data and services. The company aims to evolve from a traditional online healthcare platform to an AI-enabled ecosystem that

Tone
Positive 72/100
Event
Analyst action
Published
02 Jul 2026 18:09
Source
The Manila Times
The National Law Review Direct company coverage

POM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announce

Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against PomDoctor, Ltd. (NASDAQ: POM) and its officers. The lawsuit alleges that PomDoctor engaged in a fraudulent stock promotion scheme involving misinformation and coordinated dumping of shares by insiders

Tone
Negative 8/100
Event
Regulatory and legal
Published
01 Jul 2026 05:10
Source
The National Law Review
TradingKey Direct company coverage

PomDoctor Ltd (POM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for PomDoctor Ltd (POM) for FY2024 and FY2023, categorized by business segment. It details the proportion of revenue generated from prescription drugs, over-the-counter medicines, traditional Chinese medicine, online consultation, and med

Tone
Neutral 50/100
Event
Earnings
Published
18 Jun 2026 23:39
Source
TradingKey
TradingKey Direct company coverage

PomDoctor Ltd (POM) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of PomDoctor Ltd's (POM) dividend and stock split history. It notes that no dividends have been distributed by the company over the past five years. The only recorded stock split event for POM is a 18-to-1 merger on May 28, 2026.

Tone
Neutral 50/100
Event
Deals and strategy
Published
18 Jun 2026 09:09
Source
TradingKey
Investing.com South Africa Direct company coverage

Pomdoctor to implement 1-for-18 reverse ADS split June 22 By Investing.com

Pomdoctor Limited announced a 1-for-18 reverse American Depositary Share (ADS) split, effective June 22, 2026. This action will change the ADS ratio from one ADS representing one-sixth of a Class A ordinary share to one ADS representing three Class A ordinary shares. The reverse

Tone
Negative 18/100
Event
Market update
Published
17 Jun 2026 23:40
Source
Investing.com South Africa
TradingKey Direct company coverage

PomDoctor Ltd (POM) Institutional Confidence

This article provides an "Institutional Confidence" score for PomDoctor Ltd (POM), detailing shares held by various institutions like XTX Markets LLC, Millennium Management LLC, and UBS Financial Services, Inc. It shows a previous score of 0.00 with no change, indicating a stable

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 11:39
Source
TradingKey
TradingKey Direct company coverage

PomDoctor Ltd (POM) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of PomDoctor Ltd (POM), noting the current stock price, market capitalization, and the lack of disclosed relevant data for key valuation metrics such as P/E, P/B, P/S, and P/CF ratios. It highlights that the company has not yet provided

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 11:39
Source
TradingKey
Stock Titan Direct company coverage

Own Pomdoctor ADSs? 18 old shares will become 1 on June 22

POMDOCTOR (NASDAQ:POM) has announced that its ADS-to-Class A ordinary share ratio will change effective June 22, 2026. This adjustment means that 18 existing ADSs will be consolidated into 1 new ADS, effectively a one-for-eighteen reverse ADS split. The change will happen automat

Tone
Negative 37/100
Event
Market update
Published
16 Jun 2026 04:10
Source
Stock Titan
GuruFocus Direct company coverage

POM Stockholder Alert: Robbins LLP Reminds Investors of the Clas

Robbins LLP has reminded investors of a class action lawsuit filed against POMDoctor, Ltd. (NASDAQ: POM) concerning a "pump-and-dump" scheme. The lawsuit alleges that POMDoctor's stock price surged before its IPO due to a social media-orchestrated scheme involving false claims an

Tone
Negative 19/100
Event
Regulatory and legal
Published
08 Jun 2026 19:10
Source
GuruFocus
Intellectia AI Direct company coverage

POM Should I Buy

An analysis suggests that PomDoctor Ltd (POM) is not a good buy for long-term investors. The stock exhibits weak technical momentum, negative news sentiment regarding an ADS ratio change, and a lack of strong fundamental or analyst support. Despite a slight pre-market bounce, the

Tone
Negative 18/100
Event
Analyst action
Published
30 May 2026 05:09
Source
Intellectia AI
Market source Direct company coverage

POMDOCTOR LIMITED Announces Plan to Implement ADS Ratio Change

POMDOCTOR LIMITED (NASDAQ: POM), an online medical services platform in China, announced a plan to change its American Depositary Shares (ADS) ratio. The new ratio will be one ADS representing three Class A ordinary shares, equivalent to a one-for-eighteen reverse ADS split for c

Tone
Neutral 50/100
Event
Market update
Published
27 May 2026 19:40
Source
Market source
Finviz Direct company coverage

POM

PomDoctor Ltd ADR (POM) closed at $0.1156, up 6.15%. The company, which specializes in online medical services for chronic disease management and pharmaceutical services in China, recently announced its fiscal year 2025 financial results. It has also been focusing on "AI + Medica

Tone
Neutral 50/100
Event
Earnings
Published
27 May 2026 01:39
Source
Finviz
FinancialContent Direct company coverage

POMDOCTOR LIMITED - American Depositary Shares (NQ: POM

This article provides recent news headlines regarding POMDOCTOR LIMITED (NASDAQ: POM). The news primarily focuses on several law firms announcing class action lawsuits against the company, urging investors to secure counsel. The latest price for POM is also noted as 0.1133, down

Tone
Negative 18/100
Event
Regulatory and legal
Published
15 May 2026 08:40
Source
FinancialContent
Simply Wall Street Direct company coverage

Pomdoctor (NasdaqGM:POM) Stock Price

Pomdoctor Limited (NasdaqGM:POM) has a market capitalization of US$13.4 million, with its stock price down 97.19% over the past year. The company recently announced a strategic upgrade focusing on AI and medical-grade smart wearables for chronic disease management, despite facing

Tone
Negative 19/100
Event
Analyst action
Published
14 May 2026 21:40
Source
Simply Wall Street
www.marketscreener.com Direct company coverage

POMDOCTOR : Announces Fiscal Year 2025 Financial Results

POMDOCTOR Limited announced its financial results for fiscal year 2025, reporting a 16.7% increase in net revenues to RMB399.9 million, driven largely by its Internet hospital business and online pharmacy sales. Despite a net loss of RMB130.9 million, primarily due to IPO-related

Tone
Neutral 50/100
Event
Earnings
Published
14 May 2026 21:10
Source
www.marketscreener.com
Moomoo Direct company coverage

POMDOCTOR LIMITED SPON ADS EACH REP 0.16 CL A Company Profile & Introduction

This article provides a company profile and introduction for POMDOCTOR LIMITED SPON ADS EACH REP 0.16 CL A. Details about its operations and market position are typically covered in such profiles.

Tone
Neutral 50/100
Event
Market update
Published
11 May 2026 20:09
Source
Moomoo
TradingKey Direct company coverage

PomDoctor Ltd POM

This page provides an overview of PomDoctor Ltd (POM), including its current stock price of $0.155, which is up 106.67%. It also shows the company's market capitalization and offers sections for financial data, discussions, and analysis. The quotes are delayed by 15 minutes, and

Tone
Positive 70/100
Event
Market update
Published
11 May 2026 16:39
Source
TradingKey